首页 | 本学科首页   官方微博 | 高级检索  
     

开搏通治疗肾移植术后红细胞增多症
引用本文:王平贤 张艮甫. 开搏通治疗肾移植术后红细胞增多症[J]. 中华泌尿外科杂志, 1996, 17(2): 82-84
作者姓名:王平贤 张艮甫
作者单位:第三军医大学第二附属医院泌尿外科
摘    要:自1993年11月~1995年3月,用血管紧张素转化酶抑制剂开搏通治疗肾移植后红细胞增多症9例。结果:服用开搏通2个月后,其过高的血红蛋白明显下降,3个月后有7例红细胞压积(HCT)降为正常,另2例分别在开搏通治疗3.5个月和4个月后降为正常,此后HCT稳定在正常范围内。1例停药2个月后红细胞增多症复发,但再次服用开搏通效果良好。有2例停药已分别4个月和7个月,至今HCT正常。结果显示,开搏通是一种治疗肾移植后红细胞增多症的安全、有效的药物。

关 键 词:移植,肾,红细胞增多症,红细胞压积

Captopril in the treatment of erythrocytosis after renal transplantation
Wang Pingxian, ZhangYinpu,Wang Zehou,et al.. Captopril in the treatment of erythrocytosis after renal transplantation[J]. Chinese Journal of Urology, 1996, 17(2): 82-84
Authors:Wang Pingxian   ZhangYinpu  Wang Zehou  et al.
Abstract:renal allograft recipients complicating erythrocytosis were treated with captopril.A significant deline of hematocrit was observed two months after the treatment and returned to normal after four months in all. The hematocrit has been stabilized and no patient becomes anemia.One of the patients discontinued captopril and erythrocytosis recurred after two months but satisfactory therapeatic response was observed again after the resumed use of captopril.Another two patients have discontinued captopril for 4 to 7 months with no recurrence of erythrocytosis. Captopril has been well tolerated by all the patients.
Keywords:Transplantation  Kidney  Polycythemia  Hematocrit  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号